Stock Events

Stock Events

Evogene 

$0.5625
45
+$0.00+0.36% Friday 20:00
+$0.04+6.67%Friday 23:57After hours

Statistics

Day High
0.5624
Day Low
0.5571
52W High
1.5
52W Low
0.37
Volume
1,496
Avg. Volume
-
Mkt Cap
8.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.63
-0.27
0.09
0.44
Expected EPS
-0.27
Actual EPS
N/A

Financials

-220.22%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.85MRevenue
-8.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVGN. It's not an investment recommendation.
Tesla
11
TSLA
Palantir Technologies
11
PLTR
NVIDIA
8
NVDA
Apple
7
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine operates in the genome editing field, directly competing with Evogene's computational biology approach for developing improved plant traits and medical solutions.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is involved in gene editing, a similar biotech space where Evogene operates, making them competitors in the development of genetic engineering solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is another key player in the CRISPR/Cas9 technology for genome editing, competing with Evogene's genomic analysis and engineering.
Beam Therapeutics
BEAM
Mkt Cap2.76B
Beam Therapeutics competes with Evogene in the precise editing of DNA, which is crucial for advancements in agriculture and therapeutics.
Corteva
CTVA
Mkt Cap51.16B
Corteva Agriscience operates in the agricultural sector, focusing on seed technologies and crop protection, areas where Evogene also aims to innovate.
Bionano Genomics
BNGO
Mkt Cap13.9M
Bionano Genomics provides genomic analysis tools, competing with Evogene's computational genomic approaches to understand complex biological systems.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers long-read sequencing technologies, which are essential for the genomic research and development efforts that Evogene undertakes.
Twist Bioscience
TWST
Mkt Cap7.44B
Twist Bioscience operates in the synthetic biology space, manufacturing DNA synthesis products that are in direct competition with Evogene's genomic and molecular research.
Adaptive Biotechnologies
ADPT
Mkt Cap3.94B
Adaptive Biotechnologies is involved in the genetic immunosequencing space, competing with Evogene's approach to leveraging computational biology for understanding and manipulating biological systems.

About

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
Show more...
CEO
Ofer Haviv
Employees
52
Country
Israel
ISIN
IL0011050551

Listings

XNAS
US
EVGN
TA
IL
EVGN.TA
BOATS
BOATS
EVGN.BOATS

0 Comments

Share your thoughts

FAQ

What is Evogene stock price today?▼
The current price of EVGN is $0.56 USD — it has increased by +0.36% in the past 24 hours. Watch Evogene stock price performance more closely on the chart.
What is Evogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Evogene stocks are traded under the ticker EVGN.
Is Evogene stock price growing?▼
EVGN stock has fallen by -6.37% compared to the previous week, the month change is a +3.65% rise, over the last year Evogene has showed a -57.06% decrease.
What is Evogene market cap?▼
Today Evogene has the market capitalization of 8.89M
When is the next Evogene earnings date?▼
Evogene is going to release the next earnings report on November 18, 2026.
What were Evogene earnings last quarter?▼
EVGN earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.27 USD resulting in a +48.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Evogene revenue for the last year?▼
Evogene revenue for the last year amounts to 3.85M USD.
What is Evogene net income for the last year?▼
EVGN net income for the last year is -8.49M USD.
How many employees does Evogene have?▼
As of August 23, 2026, the company has 52 employees.
In which sector is Evogene located?▼
Evogene operates in the Health & Wellness sector.
When did Evogene complete a stock split?▼
The last stock split for Evogene was on July 28, 2024 with a ratio of 1:10.
Where is Evogene headquartered?▼
Evogene is headquartered in Rehovot, Israel.